Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors

JOURNAL ARTICLE published June 2017 in Clinical and Translational Oncology

Authors: I. Pajares Bernad | J. Martínez Trufero | L. Calera Urquizu | R. A. Pazo Cid | A. Cebollero de Miguel | M. J. Agustin | M. Lanzuela | A. Antón